Bayer Closes $589 Million Acquisition of China OTC/TCM Maker

Bayer AG closed its $589 million acquisition of China's Dihon Pharmaceutical Group, a privately held healthcare products company. Dihon specializes in OTC dermatology products and TCM products for women’s health. The deal was originally announced in February. Bayer is an active M&A player in OTC healthcare: last month, Bayer completed its $14.2 billion acquisition of Merck's global healthcare products business. More details.... Stock Symbols: (XETRA: BAYN) (NYSE: MRK) Share this with colleagues: // //